Latest Reports
Antimicrobial Susceptibility Testing Market - Strategic Insights and Forecasts (2026-2035)
The global antimicrobial susceptibility testing (AST) market is projected to witness significant growth during 2021–2035, driven by the rising prevalence of antimicrobial resistance (AMR), increasing incidence of healthcare-associated infec...
PD-L1 Testing Market - Strategic Insights and Forecasts (2026-2035)
The PD-L1 testing market serves as a critical component of precision oncology by identifying patients who are most likely to benefit from immune checkpoint inhibitor therapies. The market is transitioning from a companion diagnostic-centere...
Multi-Cancer Early Detection Market - Strategic Insights and Forecasts (2026-2035)
The multi-cancer early detection (MCED) market is evolving as liquid biopsy technologies expand beyond single-cancer screening toward identifying multiple malignancies through a single minimally invasive test. Demand is increasing because h...
MSI Testing Market - Strategic Insights and Forecasts (2026-2035)
Microsatellite instability (MSI) testing is becoming an essential component of precision oncology because it identifies tumors with deficient DNA mismatch repair (dMMR), enabling clinicians to select patients who are more likely to benefit ...
Circulating Tumor Cell Testing Market - Strategic Insights and Forecasts (2026-2035)
The circulating tumor cell (CTC) testing market is becoming an integral component of precision oncology because it enables minimally invasive assessment of tumor biology throughout the disease continuum. The market supports cancer detection...
Precision Oncology Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
Precision oncology diagnostics defines the analytical framework that identifies genomic, transcriptomic, proteomic, and biomarker alterations guiding individualized cancer treatment decisions. The market encompasses laboratory-developed tes...
Cancer Biomarker Testing Market - Strategic Insights and Forecasts (2026-2035)
Cancer biomarker testing is becoming a central component of precision oncology because treatment selection increasingly depends on molecular characterization rather than tumor origin alone. The market encompasses laboratory-developed tests,...
Molecular Oncology Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The molecular oncology diagnostics market supports precision cancer management by identifying genomic, transcriptomic, and protein biomarkers that influence diagnosis, treatment selection, disease monitoring, and recurrence assessment. Clin...
Molecular Pathology Services Market - Strategic Insights and Forecasts (2026-2035)
The molecular pathology services market encompasses laboratory-based testing services that analyze DNA, RNA, proteins, and other molecular biomarkers to support disease diagnosis, prognosis, treatment selection, and monitoring. The market s...
Diagnostics for Gastric Cancer Market - Strategic Insights and Forecasts (2026-2035)
The diagnostics for gastric cancer market encompasses technologies and services used to detect, characterize, stratify, and monitor gastric malignancies through endoscopic evaluation, histopathology, molecular testing, biomarker analysis, a...
Diagnostics Applicable Across Multiple Cancer Types Market - Strategic Insights and Forecasts (2026-2035)
The Diagnostics Applicable Across Multiple Cancer Types market consists of technologies and testing platforms that identify, characterize, monitor, or stratify multiple cancer indications through a single diagnostic approach. These solution...
Ovarian Cancer Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The ovarian cancer diagnostics market encompasses technologies, assays, imaging modalities, and molecular testing solutions used for the detection, characterization, monitoring, and risk assessment of ovarian malignancies. The market functi...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.